References
- Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
- Federal Ministry of Health. Saving newborn lives in Nigeria: newborn health in the context of the integrated maternal, newborn and child health strategy, save the children, Jhpiego. 2nd ed. Abuja: Federal Ministry of Health; 2011.
- UNICEF. Maternal and newborn health disparities in Nigeria. Key facts. 2015. https://data.unicef.org/wp-content/uploads/country.
- Polin RA, Carlo WA, Committee on Fetus and Newborn, et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133(1);156. originally published online December 30:2013.
- Halliday HL. Surfactants: past, present and future. J Perinatol. 2008;28:S47–SS56.
- Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959;97(5, Part 1):517–523.
- Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2000;2(2):CD001149.
- Welcome MO, The Nigerian health care system: need for integrating adequate medical intelligence and surveillance systems. J Pharm Bioall Sci. 2011;3:470–479.
- Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107(1):1–13.
- Fujiwara T, Maeta H, Chida S, et al. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980;1(8159):55–59.
- Greenough A, Morley CJ, Wood S, et al. Effect of artificial surfactant on lung function on preterm neonates. Prog Respir Res. 1984;18:263–266.
- Niemarkt HJ, Hütten MC, Kramer BW. Surfactant for respiratory distress syndrome: new ideas on a familiar drug with innovative applications. Neonatology. 2017;111(4):408–414.
- Okonkwo I, Abhulimhen-Iyoha B, Okolo A. Scope of neonatal care services in major Nigerian hospitals. Nig J Paed. 2016;43(1):8–13. https://www.ajol.info/index.php/njp/issue/archive.
- Vidyasagar D, Velaphi S, Bhat VB, et al. Surfactant replacement therapy in developing countries. Neonatology. 2011;99(4):355–366.
- Committee on Fetus and Newborn, American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics. 2014;133(1):171–174.
- Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2010;1(1):CD001079.
- Kamath BD, MacGuire ER, McClure EM, et al. Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries. Pediatrics. 2011;127(6):1139–1146.
- Okolo AA, Okonkwo IR, Ideh RC. Challenges and opportunities for neonatal respiratory support in Nigeria: a case for regionalisation of care. Nig J Paed. 2016;43(2):64–69. http://dx.doi.org/10.4314/njp.v43i2.1
- Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.
- Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3(3):CD000510.
- Saugstad OD. Reducing global neonatal mortality is possible. Neonatology. 2011;99(4):250–257.
- Neggers Y, Crowe K. Low birth weight outcomes: why better in Cuba than Alabama? J Am Board Fam Med. 2013;26(2):187–195.
- WHO. Fact sheets. WHO Recommendations on Interventions to Improve Preterm Birth Outcomes. February 2018.
- Maria da Conceição Nascimento C, Andrade Mota EL, Jairnilson SP, et al. Infant mortality in Brazil during recent periods of economic crisis. Rev Saúde Publ. 2003;37(6):699–706.